Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric adenocarcinoma

• 主要な著者: Moritz Jesinghaus (著者), Anna‐Lina Herz (著者), Meike Kohlruss (著者), Miguel Silva (著者), Albert Grass (著者), Sebastian Lange (著者), Alexander Novotny (著者), Katja Ott (著者), Thomas Schmidt (著者), Matthias Gaida (著者), Alexander Hapfelmeier (著者), Carsten Denkert (著者), Wilko Weichert (著者), Gisela Keller (著者)
• フォーマット: 図書
• 出版事項: Wiley, 2022-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Tumour budding (TB) has been associated with adverse clinicopathological factors and poor survival in a plethora of therapy‐naïve carcinoma entities including gastric adenocarcinoma (GC). As conventional histopathological grading is usually omitted in the post‐neoadjuvant setting of GC, ou...